Pfizer had clues its blockbuster drug could prevent Alzheimer's. Why didn't it tell the world?
A team of researchers inside Pfizer made a startling find in 2015: The company's blockbuster rheumatoid arthritis therapy Enbrel, a powerful anti-inflammatory drug, appeared to red…
